{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:53:55Z","timestamp":1792155235052,"version":"4.4.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12010-023-04752-y","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T01:01:36Z","timestamp":1705971696000},"page":"5843-5858","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mesenchymal Stem Cell-Induced Neuroprotection in Pediatric Neurological Diseases: Recent Update of Underlying Mechanisms and Clinical Utility"],"prefix":"10.1007","volume":"196","author":[{"given":"Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4960-8047","authenticated-orcid":false,"given":"Wenchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"issue":"2","key":"4752_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12264-017-0201-7","volume":"34","author":"FJ Mirza","year":"2018","unstructured":"Mirza, F. J., & Zahid, S. (2018). The role of synapsins in neurological disorders. Neuroscience Bulletin, 34(2), 349\u2013358.","journal-title":"Neuroscience Bulletin"},{"issue":"5","key":"4752_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","volume":"68","author":"D Hirtz","year":"2007","unstructured":"Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A., & Zalutsky, R. (2007). How common are the \u201ccommon\u201d neurologic disorders? Neurology., 68(5), 326\u2013337.","journal-title":"Neurology."},{"issue":"12","key":"4752_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1136\/archdischild-2018-316519","volume":"104","author":"J Raper","year":"2019","unstructured":"Raper, J., Currigan, V., Fothergill, S., Stone, J., & Forsyth, R. J. (2019). Long-term outcomes of functional neurological disorder in children. Archives of Disease in Childhood, 104(12), 1155\u20131160.","journal-title":"Archives of Disease in Childhood"},{"key":"4752_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2022.09.005","volume":"138","author":"P Chand","year":"2023","unstructured":"Chand, P., Sultan, T., Kulsoom, S., Jan, F., Ibrahim, S., Mukhtiar, K., et al. (2023). Spectrum of common pediatric neurological disorders: A cross-sectional study from three tertiary care centres across Pakistan. Pediatric Neurology, 138, 33\u201337.","journal-title":"Pediatric Neurology"},{"key":"4752_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pedn.2022.04.014","volume":"65","author":"M Kilmer","year":"2022","unstructured":"Kilmer, M., & Boykin, A. (2022). Analysis of the 2000 to 2018 autism and developmental disabilities monitoring network surveillance reports: Implications for primary care clinicians. Journal of Pediatric Nursing, 65, 55\u201368.","journal-title":"Journal of Pediatric Nursing"},{"issue":"12","key":"4752_CR6","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/dmcn.15346","volume":"64","author":"S McIntyre","year":"2022","unstructured":"McIntyre, S., Goldsmith, S., Webb, A., Ehlinger, V., Hollung, S. J., McConnell, K., et al. (2022). Global prevalence of cerebral palsy: A systematic analysis. Developmental Medicine and Child Neurology, 64(12), 1494\u20131506.","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"4","key":"4752_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.14336\/AD.2021.0219","volume":"12","author":"M Hollist","year":"2021","unstructured":"Hollist, M., Au, K., Morgan, L., Shetty, P. A., Rane, R., Hollist, A., et al. (2021). Pediatric stroke: Overview and recent updates. Aging & Disease, 12(4), 1043\u20131048.","journal-title":"Aging & Disease"},{"issue":"5","key":"4752_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000518281","volume":"55","author":"DM Oleske","year":"2021","unstructured":"Oleske, D. M., Cheng, X., Jeong, A., & Arndt, T. J. (2021). Pediatric acute ischemic stroke by age-group: A systematic review and meta-analysis of published studies and hospitalization records. Neuroepidemiology., 55(5), 331\u2013341.","journal-title":"Neuroepidemiology."},{"key":"4752_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21037\/sci.2019.08.11","volume":"6","author":"P Saeedi","year":"2019","unstructured":"Saeedi, P., Halabian, R., & Fooladi, A. A. I. (2019). A revealing review of mesenchymal stem cells therapy, clinical perspectives and modification strategies. Stem Cell Investigation, 6, 34\u201340.","journal-title":"Stem Cell Investigation"},{"issue":"7737","key":"4752_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/d41586-019-00178-x","volume":"565","author":"D Cyranoski","year":"2019","unstructured":"Cyranoski, D. (2019). Japan\u2019s approval of stem-cell treatment for spinal-cord injury concerns scientists. Nature., 565(7737), 544\u2013546.","journal-title":"Nature."},{"key":"4752_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2184.2008.00486.x","volume":"41","author":"DC Hess","year":"2008","unstructured":"Hess, D. C., & Borlongan, C. (2008). Stem cells and neurological diseases. Cell Proliferation, 41, 94\u2013114.","journal-title":"Cell Proliferation"},{"issue":"7","key":"4752_CR12","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.4103\/1673-5374.235085","volume":"13","author":"C-G Song","year":"2018","unstructured":"Song, C.-G., Zhang, Y.-Z., Wu, H.-N., Cao, X.-L., Guo, C.-J., Li, Y.-Q., et al. (2018). Stem cells: A promising candidate to treat neurological disorders. Neural Regeneration Research, 13(7), 1294\u20131299.","journal-title":"Neural Regeneration Research"},{"issue":"1","key":"4752_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42269-019-0078-x","volume":"43","author":"GI Fouad","year":"2019","unstructured":"Fouad, G. I. (2019). Stem cells as a promising therapeutic approach for Alzheimer\u2019s disease: A review. Bulletin of the National Research Centre, 43(1), 1\u201320.","journal-title":"Bulletin of the National Research Centre"},{"key":"4752_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.reth.2018.08.001","volume":"9","author":"T Mukai","year":"2018","unstructured":"Mukai, T., Tojo, A., & Nagamura-Inoue, T. (2018). Mesenchymal stromal cells as a potential therapeutic for neurological disorders. Regenerative Therapy, 9, 32\u201337.","journal-title":"Regenerative Therapy"},{"key":"4752_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01839-9","volume":"11","author":"Z Li","year":"2020","unstructured":"Li, Z., Dong, X., Tian, M., Liu, C., Wang, K., Li, L., et al. (2020). Stem cell-based therapies for ischemic stroke: A systematic review and meta-analysis of clinical trials. Stem Cell Research & Therapy, 11, 1\u201313.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"4752_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12916-022-02482-2","volume":"20","author":"Z Shang","year":"2022","unstructured":"Shang, Z., Wang, M., Zhang, B., Wang, X., & Wanyan, P. (2022). Clinical translation of stem cell therapy for spinal cord injury still premature: Results from a single-arm meta-analysis based on 62 clinical trials. BMC Medicine, 20(1), 284\u2013291.","journal-title":"BMC Medicine"},{"issue":"1","key":"4752_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-023-00269-3","volume":"43","author":"A Morizane","year":"2023","unstructured":"Morizane, A. (2023). Cell therapy for Parkinson\u2019s disease with induced pluripotent stem cells. Inflammation and Regeneration, 43(1), 16\u201325.","journal-title":"Inflammation and Regeneration"},{"issue":"2","key":"4752_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/path.2474","volume":"217","author":"M Walker","year":"2009","unstructured":"Walker, M., Patel, K., & Stappenbeck, T. (2009). The stem cell niche. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland., 217(2), 169\u2013180.","journal-title":"The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland."},{"issue":"4","key":"4752_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.stem.2012.02.018","volume":"10","author":"AJ Wagers","year":"2012","unstructured":"Wagers, A. J. (2012). The stem cell niche in regenerative medicine. Cell Stem Cell, 10(4), 362\u2013369.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"4752_CR20","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1016\/j.biomaterials.2009.12.006","volume":"31","author":"J Tang","year":"2010","unstructured":"Tang, J., Peng, R., & Ding, J. (2010). The regulation of stem cell differentiation by cell-cell contact on micropatterned material surfaces. Biomaterials., 31(9), 2470\u20132476.","journal-title":"Biomaterials."},{"key":"4752_CR21","doi-asserted-by":"crossref","unstructured":"Hosseini, K., Lekholm, E., Ahemaiti, A., & Fredriksson, R. (2020). Differentiation of human embryonic stem cells into neuron, cholinergic, and glial cells. Stem Cells International, 8827874.","DOI":"10.1155\/2020\/8827874"},{"issue":"5","key":"4752_CR22","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/mt.2016.12","volume":"24","author":"K Pollock","year":"2016","unstructured":"Pollock, K., Dahlenburg, H., Nelson, H., Fink, K. D., Cary, W., Hendrix, K., et al. (2016). Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington\u2019s disease mouse models. Molecular Therapy, 24(5), 965\u2013977.","journal-title":"Molecular Therapy"},{"key":"4752_CR23","doi-asserted-by":"publisher","first-page":"773375","DOI":"10.3389\/fncel.2021.773375","volume":"15","author":"L Wang","year":"2021","unstructured":"Wang, L., Gu, S., Gan, J., Tian, Y., Zhang, F., Zhao, H., et al. (2021). Neural stem cells overexpressing nerve growth factor improve functional recovery in rats following spinal cord injury via modulating microenvironment and enhancing endogenous neurogenesis. Frontiers in Cellular Neuroscience, 15, 773375.","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"2","key":"4752_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1523\/JNEUROSCI.21-02-00581.2001","volume":"21","author":"JT Erickson","year":"2001","unstructured":"Erickson, J. T., Brosenitsch, T. A., & Katz, D. M. (2001). Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo. The Journal of Neuroscience, 21(2), 581\u2013589.","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"4752_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02537-w","volume":"12","author":"F Huang","year":"2021","unstructured":"Huang, F., Gao, T., Wang, W., Wang, L., Xie, Y., Tai, C., et al. (2021). Engineered basic fibroblast growth factor-overexpressing human umbilical cord-derived mesenchymal stem cells improve the proliferation and neuronal differentiation of endogenous neural stem cells and functional recovery of spinal cord injury by activating the PI3K-Akt-GSK-3\u03b2 signaling pathway. Stem Cell Research & Therapy, 12(1), 1\u201318.","journal-title":"Stem Cell Research & Therapy"},{"issue":"2","key":"4752_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/biom12020218","volume":"12","author":"AE Koutsoumparis","year":"2022","unstructured":"Koutsoumparis, A. E., Patsiarika, A., Tsingotjidou, A., Pappas, I., & Tsiftsoglou, A. S. (2022). Neural differentiation of human dental mesenchymal stem cells induced by ATRA and UDP-4: A comparative study. Biomolecules, 12(2), 218\u2013227.","journal-title":"Biomolecules"},{"key":"4752_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12264-019-00405-5","volume":"35","author":"L Tian","year":"2019","unstructured":"Tian, L., Zhu, W., Liu, Y., Gong, Y., Lv, A., Wang, Z., et al. (2019). Neural stem cells transfected with leukemia inhibitory factor promote neuroprotection in a rat model of cerebral ischemia. Neuroscience Bulletin, 35, 901\u2013908.","journal-title":"Neuroscience Bulletin"},{"key":"4752_CR28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s12015-019-09917-z","volume":"15","author":"S George","year":"2019","unstructured":"George, S., Hamblin, M. R., & Abrahamse, H. (2019). Differentiation of mesenchymal stem cells to neuroglia: In the context of cell signalling. Stem Cell Reviews and Reports, 15, 814\u2013826.","journal-title":"Stem Cell Reviews and Reports"},{"key":"4752_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6676709","volume":"2021","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Yang, B., Luo, L., Li, L., Yang, X., Zhang, J., et al. (2021). Effect of NTN and Lmx1\u03b1 on the notch signaling pathway during the differentiation of human bone marrow mesenchymal stem cells into dopaminergic neuron-like cells. Parkinson's Disease, 2021, 1\u201311.","journal-title":"Parkinson's Disease"},{"key":"4752_CR30","doi-asserted-by":"crossref","unstructured":"Maeda S, Miyagawa S, Kawamura T, Shibuya T, Watanabe K, Nakagawa T, et al. (2021). Notch signaling-modified mesenchymal stem cells improve tissue perfusion by induction of arteriogenesis in a rat hindlimb ischemia model. Scientific Reports, 11(1):1-9.","DOI":"10.1038\/s41598-021-82284-3"},{"issue":"4","key":"4752_CR31","doi-asserted-by":"publisher","first-page":"104159","DOI":"10.1016\/j.isci.2022.104159","volume":"25","author":"SM Law","year":"2022","unstructured":"Law, S. M., & Zheng, J. J. (2022). Premise and peril of Wnt signaling activation through GSK-3\u03b2 inhibition. Iscience, 25(4), 104159.","journal-title":"Iscience"},{"key":"4752_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3389\/fncel.2014.00393","volume":"8","author":"J Stipursky","year":"2014","unstructured":"Stipursky, J., Francis, D., Dezonne, R. S., B\u00e9rgamo de Ara\u00fajo, A. P., Souza, L., Moraes, C. A., et al. (2014). TGF-\u03b2 1 promotes cerebral cortex radial glia-astrocyte differentiation in vivo. Frontiers in Cellular Neuroscience, 8, 393\u2013402.","journal-title":"Frontiers in Cellular Neuroscience"},{"issue":"12","key":"4752_CR33","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.3390\/ijms21124471","volume":"21","author":"H Albert-Gasc\u00f3","year":"2020","unstructured":"Albert-Gasc\u00f3, H., Ros-Bernal, F., Castillo-G\u00f3mez, E., & Olucha-Bordonau, F. E. (2020). MAP\/ERK signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes. International Journal of Molecular Sciences, 21(12), 4471\u20134478.","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"4752_CR34","first-page":"5374","volume":"23","author":"Q Wang","year":"2019","unstructured":"Wang, Q., Lu, L., & Zhou, H. (2019). Relationship between the MAPK\/ERK pathway and neurocyte apoptosis after cerebral infarction in rats. European Review for Medical and Pharmacological Sciences, 23(12), 5374\u20135381.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"24","key":"4752_CR35","doi-asserted-by":"publisher","first-page":"9683","DOI":"10.3390\/ijms21249683","volume":"21","author":"V Salari","year":"2020","unstructured":"Salari, V., Mengoni, F., Del Gallo, F., Bertini, G., & Fabene, P. F. (2020). The anti-inflammatory properties of mesenchymal stem cells in epilepsy: Possible treatments and future perspectives. International Journal of Molecular Sciences, 21(24), 9683\u20139690.","journal-title":"International Journal of Molecular Sciences"},{"key":"4752_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.omtm.2017.06.005","volume":"6","author":"M Nakajima","year":"2017","unstructured":"Nakajima, M., Nito, C., Sowa, K., Suda, S., Nishiyama, Y., Nakamura-Takahashi, A., et al. (2017). Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke. Molecular Therapy-Methods & Clinical Development, 6, 102\u2013111.","journal-title":"Molecular Therapy-Methods & Clinical Development"},{"issue":"3","key":"4752_CR37","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1007\/s12015-021-10219-6","volume":"18","author":"T Han","year":"2022","unstructured":"Han, T., Song, P., Wu, Z., Xiang, X., Liu, Y., Wang, Y., et al. (2022). MSC secreted extracellular vesicles carrying TGF-beta upregulate Smad 6 expression and promote the regrowth of neurons in spinal cord injured rats. Stem Cell Reviews and Reports, 18(3), 1078\u20131096.","journal-title":"Stem Cell Reviews and Reports"},{"key":"4752_CR38","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1007\/s12015-023-10539-9","volume":"19","author":"G Yang","year":"2023","unstructured":"Yang, G., Fan, X., Liu, Y., Jie, P., Mazhar, M., Liu, Y., et al. (2023). Immunomodulatory mechanisms and therapeutic potential of mesenchymal stem cells. Stem Cell Reviews and Reports, 19, 1214\u20131231.","journal-title":"Stem Cell Reviews and Reports"},{"issue":"2","key":"4752_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0014-4886(03)00037-2","volume":"181","author":"P Lu","year":"2003","unstructured":"Lu, P., Jones, L., Snyder, E., & Tuszynski, M. (2003). Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Experimental Neurology, 181(2), 115\u2013129.","journal-title":"Experimental Neurology"},{"issue":"1","key":"4752_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-022-03024-6","volume":"13","author":"G Bahlakeh","year":"2022","unstructured":"Bahlakeh, G., Rahbarghazi, R., Abedelahi, A., Sadigh-Eteghad, S., & Karimipour, M. (2022). Neurotrophic factor-secreting cells restored endogenous hippocampal neurogenesis through the Wnt\/\u03b2-catenin signaling pathway in AD model mice. Stem Cell Research & Therapy, 13(1), 1\u201314.","journal-title":"Stem Cell Research & Therapy"},{"issue":"6","key":"4752_CR41","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cell.2012.08.020","volume":"150","author":"P Lu","year":"2012","unstructured":"Lu, P., Wang, Y., Graham, L., McHale, K., Gao, M., Wu, D., et al. (2012). Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell., 150(6), 1264\u20131273.","journal-title":"Cell."},{"issue":"1","key":"4752_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1276-z","volume":"10","author":"X Bian","year":"2019","unstructured":"Bian, X., Ma, K., Zhang, C., & Fu, X. (2019). Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases. Stem Cell Research & Therapy, 10(1), 1\u201318.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"4752_CR43","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1371\/journal.pone.0000156","volume":"2","author":"HJ Lee","year":"2007","unstructured":"Lee, H. J., Kim, K. S., Park, I. H., & Kim, S. U. (2007). Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One, 2(1), e156.","journal-title":"PLoS One"},{"key":"4752_CR44","doi-asserted-by":"publisher","first-page":"113482","DOI":"10.1016\/j.biopha.2022.113482","volume":"153","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Liu, Q., Hu, H., Zhao, L., & Zhu, K. (2022). Progress in mesenchymal stem cell mitochondria transfer for the repair of tissue injury and treatment of disease. Biomedicine & Pharmacotherapy, 153, 113482.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"4752_CR45","doi-asserted-by":"crossref","unstructured":"Han, D., Zheng, X., Wang, X., Jin, T., Cui, L., & Chen, Z. (2020). Mesenchymal stem\/stromal cell-mediated mitochondrial transfer and the therapeutic potential in treatment of neurological diseases. Stem Cells International, 8838046.","DOI":"10.1155\/2020\/8838046"},{"issue":"4","key":"4752_CR46","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0271678X20928147","volume":"41","author":"N Tseng","year":"2021","unstructured":"Tseng, N., Lambie, S. C., Huynh, C. Q., Sanford, B., Patel, M., Herson, P. S., et al. (2021). Mitochondrial transfer from mesenchymal stem cells improves neuronal metabolism after oxidant injury in vitro: The role of Miro1. Journal of Cerebral Blood Flow & Metabolism, 41(4), 761\u2013770.","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"issue":"3","key":"4752_CR47","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4103\/1673-5374.266058","volume":"15","author":"Y Yang","year":"2020","unstructured":"Yang, Y., Ye, G., Zhang, Y.-L., He, H.-W., Yu, B.-Q., Hong, Y.-M., et al. (2020). Transfer of mitochondria from mesenchymal stem cells derived from induced pluripotent stem cells attenuates hypoxia-ischemia-induced mitochondrial dysfunction in PC12 cells. Neural Regeneration Research, 15(3), 464\u2013479.","journal-title":"Neural Regeneration Research"},{"key":"4752_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.trsl.2021.03.017","volume":"235","author":"J Zhao","year":"2021","unstructured":"Zhao, J., Qu, D., Xi, Z., Huan, Y., Zhang, K., Yu, C., et al. (2021). Mitochondria transplantation protects traumatic brain injury via promoting neuronal survival and astrocytic BDNF. Translational Research, 235, 102\u2013114.","journal-title":"Translational Research"},{"issue":"6","key":"4752_CR49","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.3390\/ijms24065712","volume":"24","author":"Y Seo","year":"2023","unstructured":"Seo, Y., Han, S., Song, B.-W., Chang, J. W., Na, Y. C., & Chang, W. S. (2023). Endogenous neural stem cell activation after low-intensity focused ultrasound-induced blood\u2013Brain barrier modulation. International Journal of Molecular Sciences, 24(6), 5712\u20135728.","journal-title":"International Journal of Molecular Sciences"},{"key":"4752_CR50","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12264-021-00667-y","volume":"37","author":"T-F Yuan","year":"2021","unstructured":"Yuan, T.-F., Dong, Y., Zhang, L., Qi, J., Yao, C., Wang, Y., et al. (2021). Neuromodulation-based stem cell therapy in brain repair: Recent advances and future perspectives. Neuroscience Bulletin, 37, 735\u2013745.","journal-title":"Neuroscience Bulletin"},{"issue":"3","key":"4752_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/stcltm\/szab022","volume":"11","author":"YK Alshoubaki","year":"2022","unstructured":"Alshoubaki, Y. K., Nayer, B., Das, S., & Martino, M. M. (2022). Modulation of the activity of stem and progenitor cells by immune cells. Stem Cells Translational Medicine, 11(3), 248\u2013258.","journal-title":"Stem Cells Translational Medicine"},{"issue":"Suppl 1","key":"4752_CR52","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.21037\/tp.2020.01.01","volume":"9","author":"DR Patel","year":"2020","unstructured":"Patel, D. R., Neelakantan, M., Pandher, K., & Merrick, J. (2020). Cerebral palsy in children: A clinical overview. Translational Pediatrics, 9(Suppl 1), S125.","journal-title":"Translational Pediatrics"},{"key":"4752_CR53","doi-asserted-by":"crossref","unstructured":"Paul, S., Nahar, A., Bhagawati, M., & Kunwar, A. J. (2022). A review on recent advances of cerebral palsy. Oxidative Medicine and Cellular Longevity, 2622310.","DOI":"10.1155\/2022\/2622310"},{"key":"4752_CR54","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2147\/NDT.S235165","volume":"16","author":"M Sadowska","year":"2020","unstructured":"Sadowska, M., Sarecka-Hujar, B., & Kopyta, I. (2020). Cerebral palsy: Current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatric Disease and Treatment, 16, 1505\u20131525.","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"7","key":"4752_CR55","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.4103\/1673-5374.300979","volume":"16","author":"Z-Y Lv","year":"2021","unstructured":"Lv, Z.-Y., Li, Y., & Liu, J. (2021). Progress in clinical trials of stem cell therapy for cerebral palsy. Neural Regeneration Research, 16(7), 1377\u20131392.","journal-title":"Neural Regeneration Research"},{"key":"4752_CR56","doi-asserted-by":"crossref","unstructured":"Pan, K., Deng, L., Chen, P., Peng, Q., Pan, J., Wu, Y., et al. (2019). Safety and feasibility of repeated intrathecal allogeneic bone marrow-derived mesenchymal stromal cells in patients with neurological diseases. Stem Cells International, 8421281.","DOI":"10.1155\/2019\/8421281"},{"issue":"5","key":"4752_CR57","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells and Development, 18(5), 683\u2013692.","journal-title":"Stem Cells and Development"},{"issue":"1","key":"4752_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/rej.2010.1130","volume":"14","author":"L Danielyan","year":"2011","unstructured":"Danielyan, L., Sch\u00e4fer, R., von Ameln-Mayerhofer, A., Bernhard, F., Verleysdonk, S., Buadze, M., et al. (2011). Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Research, 14(1), 3\u201316.","journal-title":"Rejuvenation Research"},{"issue":"12","key":"4752_CR59","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/cns.12441","volume":"21","author":"G Ji","year":"2015","unstructured":"Ji, G., Liu, M., Zhao, X. F., Liu, X. Y., Guo, Q. L., Guan, Z. F., et al. (2015). NF-\u03baB signaling is involved in the effects of intranasally engrafted human neural stem cells on neurofunctional improvements in neonatal rat hypoxic\u2013Ischemic encephalopathy. CNS Neuroscience & Therapeutics, 21(12), 926\u2013935.","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"2","key":"4752_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00431-018-3279-7","volume":"178","author":"T Keller","year":"2019","unstructured":"Keller, T., K\u00f6rber, F., Oberthuer, A., Schafmeyer, L., Mehler, K., Kuhr, K., et al. (2019). Intranasal breast milk for premature infants with severe intraventricular hemorrhage\u2014An observation. European Journal of Pediatrics, 178(2), 199\u2013206.","journal-title":"European Journal of Pediatrics"},{"issue":"19","key":"4752_CR61","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.4103\/1673-5374.141785","volume":"9","author":"J Tan","year":"2014","unstructured":"Tan, J., Zheng, X., Zhang, S., Yang, Y., Wang, X., Yu, X., et al. (2014). Response of the sensorimotor cortex of cerebral palsy rats receiving transplantation of vascular endothelial growth factor 165-transfected neural stem cells. Neural Regeneration Research, 9(19), 1763\u20131782.","journal-title":"Neural Regeneration Research"},{"issue":"5","key":"4752_CR62","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1523\/ENEURO.0369-18.2018","volume":"5","author":"P Rumajogee","year":"2018","unstructured":"Rumajogee, P., Altamentova, S., Li, L., Li, J., Wang, J., Kuurstra, A., et al. (2018). Exogenous neural precursor cell transplantation results in structural and functional recovery in a hypoxic-ischemic hemiplegic mouse model. Eneuro, 5(5), 369\u2013380.","journal-title":"Eneuro"},{"key":"4752_CR63","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00381-021-05068-0","volume":"37","author":"Y Chang","year":"2021","unstructured":"Chang, Y., Lin, S., Li, Y., Liu, S., Ma, T., & Wei, W. (2021). Umbilical cord blood CD34+ cells administration improved neurobehavioral status and alleviated brain injury in a mouse model of cerebral palsy. Child's Nervous System, 37, 2197\u20132205.","journal-title":"Child's Nervous System"},{"key":"4752_CR64","doi-asserted-by":"crossref","unstructured":"Purandare, C., Shitole, D., Belle, V., Kedari, A., Bora, N., & Joshi, M. (2012). Therapeutic potential of autologous stem cell transplantation for cerebral palsy. Case Reports in Transplantation, 825289.","DOI":"10.1155\/2012\/825289"},{"issue":"1_suppl","key":"4752_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3727\/096368912X633806","volume":"21","author":"Z Luan","year":"2012","unstructured":"Luan, Z., Liu, W., Qu, S., Du, K., He, S., Wang, Z., et al. (2012). Effects of neural progenitor cell transplantation in children with severe cerebral palsy. Cell Transplantation, 21(1_suppl), 91\u201398.","journal-title":"Cell Transplantation"},{"issue":"6","key":"4752_CR66","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jcyt.2014.01.008","volume":"16","author":"C Manc\u00edas-Guerra","year":"2014","unstructured":"Manc\u00edas-Guerra, C., Marroqu\u00edn-Escamilla, A. R., Gonz\u00e1lez-Llano, O., Villarreal-Mart\u00ednez, L., Jaime-P\u00e9rez, J. C., Garc\u00eda-Rodr\u00edguez, F., et al. (2014). Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: An open-label phase I trial. Cytotherapy., 16(6), 810\u2013820.","journal-title":"Cytotherapy."},{"issue":"12","key":"4752_CR67","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1002\/sctm.17-0102","volume":"6","author":"JM Sun","year":"2017","unstructured":"Sun, J. M., Song, A. W., Case, L. E., Mikati, M. A., Gustafson, K. E., Simmons, R., et al. (2017). Effect of autologous cord blood infusion on motor function and brain connectivity in young children with cerebral palsy: A randomized, placebo-controlled trial. Stem Cells Translational Medicine, 6(12), 2071\u20132078.","journal-title":"Stem Cells Translational Medicine"},{"key":"4752_CR68","doi-asserted-by":"crossref","unstructured":"Gu J, Huang L, Zhang C, Wang Y, Zhang R, Tu Z, et al. (2020). Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: A randomized, controlled trial. Stem Cell Research & Therapy, 11(1):1-12.","DOI":"10.1186\/s13287-019-1545-x"},{"key":"4752_CR69","doi-asserted-by":"crossref","unstructured":"Min K, Suh MR, Cho KH, Park W, Kang MS, Jang SJ, et al. (2020). Potentiation of cord blood cell therapy with erythropoietin for children with CP: A 2\u00d7 2 factorial randomized placebo-controlled trial. Stem Cell Research & Therapy, 11(1), 1-12.","DOI":"10.1186\/s13287-020-02020-y"},{"issue":"11","key":"4752_CR70","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/brain\/awh600","volume":"128","author":"B Thomas","year":"2005","unstructured":"Thomas, B., Eyssen, M., Peeters, R., Molenaers, G., Van Hecke, P., De Cock, P., et al. (2005). Quantitative diffusion tensor imaging in cerebral palsy due to periventricular white matter injury. Brain., 128(11), 2562\u20132577.","journal-title":"Brain."},{"issue":"1","key":"4752_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02513-4","volume":"12","author":"M Amanat","year":"2021","unstructured":"Amanat, M., Majmaa, A., Zarrabi, M., Nouri, M., Akbari, M. G., Moaiedi, A. R., et al. (2021). Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: A randomized double-blind sham-controlled clinical trial. Stem Cell Research & Therapy, 12(1), 1\u201315.","journal-title":"Stem Cell Research & Therapy"},{"issue":"3","key":"4752_CR72","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/braincomms\/fcac131","volume":"4","author":"CS Cox","year":"2022","unstructured":"Cox, C. S., Juranek, J., Kosmach, S., Pedroza, C., Thakur, N., Dempsey, A., et al. (2022). Autologous cellular therapy for cerebral palsy: A randomized, crossover trial. Brain Communications, 4(3), 131\u2013143.","journal-title":"Brain Communications"},{"issue":"1","key":"4752_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-022-02636-y","volume":"22","author":"M Zarrabi","year":"2022","unstructured":"Zarrabi, M., Akbari, M. G., Amanat, M., Majmaa, A., Moaiedi, A. R., Montazerlotfelahi, H., et al. (2022). The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: A randomized double-blind sham-controlled clinical trial. BMC Neurology, 22(1), 1\u201313.","journal-title":"BMC Neurology"},{"issue":"7","key":"4752_CR74","first-page":"2330","volume":"26","author":"D Maric","year":"2022","unstructured":"Maric, D., Radomir, M., Milankov, Z., Stanojevic, I., Vojvodic, D., Velikic, G., et al. (2022). Encouraging effect of autologous bone marrow aspirate concentrate in rehabilitation of children with cerebral palsy. European Review for Medical and Pharmacological Sciences, 26(7), 2330\u20132342.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"9","key":"4752_CR75","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/sctm.20-0470","volume":"10","author":"JM Sun","year":"2021","unstructured":"Sun, J. M., Case, L. E., Mikati, M. A., Jasien, J. M., McLaughlin, C., Waters-Pick, B., et al. (2021). Sibling umbilical cord blood infusion is safe in young children with cerebral palsy. Stem Cells Translational Medicine, 10(9), 1258\u20131265.","journal-title":"Stem Cells Translational Medicine"},{"issue":"1","key":"4752_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-022-03234-y","volume":"14","author":"Z Lv","year":"2023","unstructured":"Lv, Z., Li, Y., Wang, Y., Cong, F., Li, X., Cui, W., et al. (2023). Safety and efficacy outcomes after intranasal administration of neural stem cells in cerebral palsy: A randomized phase 1\/2 controlled trial. Stem Cell Research & Therapy, 14(1), 1\u201314.","journal-title":"Stem Cell Research & Therapy"},{"issue":"8","key":"4752_CR77","first-page":"917","volume":"12","author":"J Gautam","year":"2020","unstructured":"Gautam, J., Alaref, A., Hassan, A., Kandel, R. S., Mishra, R., & Jahan, N. (2020). Safety and efficacy of stem cell therapy in patients with ischemic stroke. Cureus., 12(8), 917\u2013930.","journal-title":"Cureus."},{"key":"4752_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-013-0422-8","volume":"14","author":"AL Numis","year":"2014","unstructured":"Numis, A. L., & Fox, C. K. (2014). Arterial ischemic stroke in children: Risk factors and etiologies. Current Neurology and Neuroscience Reports, 14, 1\u20139.","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"13","key":"4752_CR79","first-page":"2925","volume":"10","author":"M Sanchez-Diaz","year":"2021","unstructured":"Sanchez-Diaz, M., Qui\u00f1ones-Vico, M. I., Sanabria de la Torre, R., Montero-V\u00edlchez, T., Sierra-S\u00e1nchez, A., Molina-Leyva, A., et al. (2021). Biodistribution of mesenchymal stromal cells after administration in animal models and humans: A systematic review. Journal of. Clinical Medicine, 10(13), 2925\u20132940.","journal-title":"Clinical Medicine"},{"issue":"2","key":"4752_CR80","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/biomedicines10020353","volume":"10","author":"IL Gubskiy","year":"2022","unstructured":"Gubskiy, I. L., Namestnikova, D. D., Revkova, V. A., Cherkashova, E. A., Sukhinich, K. K., Beregov, M. M., et al. (2022). The impact of cerebral perfusion on mesenchymal stem cells distribution after intra-arterial transplantation: A quantitative MR study. Biomedicines, 10(2), 353\u2013369.","journal-title":"Biomedicines"},{"issue":"5","key":"4752_CR81","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/STROKEAHA.117.018288","volume":"49","author":"R Guzman","year":"2018","unstructured":"Guzman, R., Janowski, M., & Walczak, P. (2018). Intra-arterial delivery of cell therapies for stroke. Stroke., 49(5), 1075\u20131082.","journal-title":"Stroke."},{"issue":"7","key":"4752_CR82","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1212\/WNL.0000000000011440","volume":"96","author":"J-W Chung","year":"2021","unstructured":"Chung, J.-W., Chang, W. H., Bang, O. Y., Moon, G. J., Kim, S. J., Kim, S.-K., et al. (2021). Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke. Neurology., 96(7), e1012\u2013e1e23.","journal-title":"Neurology."},{"key":"4752_CR83","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1007\/s00415-020-10138-5","volume":"268","author":"J Li","year":"2021","unstructured":"Li, J., Zhang, Q., Wang, W., Lin, F., Wang, S., & Zhao, J. (2021). Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. Journal of Neurology, 268, 4095\u20134107.","journal-title":"Journal of Neurology"},{"key":"4752_CR84","doi-asserted-by":"publisher","first-page":"641970","DOI":"10.3389\/fnins.2021.641970","volume":"15","author":"DD Namestnikova","year":"2021","unstructured":"Namestnikova, D. D., Gubskiy, I. L., Revkova, V. A., Sukhinich, K. K., Melnikov, P. A., Gabashvili, A. N., et al. (2021). Intra-arterial stem cell transplantation in experimental stroke in rats: Real-time MR visualization of transplanted cells starting with their first pass through the brain with regard to the therapeutic action. Frontiers in Neuroscience, 15, 641970.","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"4752_CR85","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/life13020288","volume":"13","author":"EA Cherkashova","year":"2023","unstructured":"Cherkashova, E. A., Namestnikova, D. D., Gubskiy, I. L., Revkova, V. A., Sukhinich, K. K., Melnikov, P. A., et al. (2023). Dynamic MRI of the mesenchymal stem cells distribution during intravenous transplantation in a rat model of ischemic stroke. Life, 13(2), 288\u2013298.","journal-title":"Life"},{"issue":"10","key":"4752_CR86","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1021\/acsbiomaterials.2c00228","volume":"8","author":"R Xu","year":"2022","unstructured":"Xu, R., Duan, C., Meng, Z., Zhao, J., He, Q., Zhang, Q., et al. (2022). Lipid microcapsules promoted neural stem cell survival in the infarcted area of mice with ischemic stroke by inducing autophagy. ACS Biomaterials Science & Engineering, 8(10), 4462\u20134473.","journal-title":"ACS Biomaterials Science & Engineering"},{"issue":"7","key":"4752_CR87","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/1535370216636722","volume":"241","author":"CP Rivera","year":"2016","unstructured":"Rivera, C. P., Veneziani, A., Ware, R. E., & Platt, M. O. (2016). Sickle cell anemia and pediatric strokes: computational fluid dynamics analysis in the middle cerebral artery. Experimental Biology and Medicine, 241(7), 755\u2013765.","journal-title":"Experimental Biology and Medicine"},{"issue":"11","key":"4752_CR88","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/stem.3080","volume":"37","author":"FS Vahidy","year":"2019","unstructured":"Vahidy, F. S., Haque, M. E., Rahbar, M. H., Zhu, H., Rowan, P., Aisiku, I. P., et al. (2019). Intravenous bone marrow mononuclear cells for acute ischemic stroke: Safety, feasibility, and effect size from a phase I clinical trial. Stem Cells, 37(11), 1481\u20131491.","journal-title":"Stem Cells"},{"issue":"5","key":"4752_CR89","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/2040620713483063","volume":"4","author":"S Shenoy","year":"2013","unstructured":"Shenoy, S. (2013). Hematopoietic stem-cell transplantation for sickle cell disease: Current evidence and opinions. Therapeutic Advances in Hematology, 4(5), 335\u2013344.","journal-title":"Therapeutic Advances in Hematology"},{"issue":"3","key":"4752_CR90","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s11764-021-01063-1","volume":"16","author":"NL Wu","year":"2022","unstructured":"Wu, N. L., Krull, K. R., Cushing-Haugen, K. L., Ullrich, N. J., Kadan-Lottick, N. S., Lee, S. J., et al. (2022). Long-term neurocognitive and quality of life outcomes in survivors of pediatric hematopoietic cell transplant. Journal of Cancer Survivorship, 16(3), 696\u2013704.","journal-title":"Journal of Cancer Survivorship"},{"issue":"5","key":"4752_CR91","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1016\/j.bbmt.2019.01.008","volume":"25","author":"AA King","year":"2019","unstructured":"King, A. A., McKinstry, R. C., Wu, J., Eapen, M., Abel, R., Varughese, T., et al. (2019). Functional and radiologic assessment of the brain after reduced-intensity unrelated donor transplantation for severe sickle cell disease: Blood and marrow transplant clinical trials network study 0601. Biology of Blood and Marrow Transplantation, 25(5), e174\u2013e1e8.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"12","key":"4752_CR92","first-page":"1018","volume":"27","author":"JL Carpenter","year":"2021","unstructured":"Carpenter, J. L., Nickel, R. S., Webb, J., Khademian, Z., Speller-Brown, B., Majumdar, S., et al. (2021). Low rates of cerebral infarction after hematopoietic stem cell transplantation in patients with sickle cell disease at high risk for stroke. Transplantation and Cellular. Therapy., 27(12), 1018 e1-. e9.","journal-title":"Therapy."},{"issue":"1","key":"4752_CR93","doi-asserted-by":"publisher","first-page":"8","DOI":"10.14740\/jh949","volume":"11","author":"A Al-Jefri","year":"2022","unstructured":"Al-Jefri, A., Siddiqui, K., Al-Oraibi, A., Al-Seraihy, A., Al Ahmari, A., Ghemlas, I., et al. (2022). Hematopoietic stem cell transplantation stabilizes cerebral vasculopathy in high-risk pediatric sickle cell disease patients: Evidence from a referral transplant center. Journal of Hematology, 11(1), 8\u201324.","journal-title":"Journal of Hematology"},{"issue":"1","key":"4752_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0138-4","volume":"6","author":"C Lord","year":"2020","unstructured":"Lord, C., Brugha, T. S., Charman, T., Cusack, J., Dumas, G., Frazier, T., et al. (2020). Autism spectrum disorder. Nature Reviews. Disease Primers, 6(1), 1\u201323.","journal-title":"Nature Reviews. Disease Primers"},{"key":"4752_CR95","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3389\/fnins.2018.01029","volume":"12","author":"R Jure","year":"2019","unstructured":"Jure, R. (2019). Autism pathogenesis: The superior colliculus. Frontiers in Neuroscience, 12, 1029\u20131041.","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"4752_CR96","first-page":"390","volume":"11","author":"S Medavarapu","year":"2019","unstructured":"Medavarapu, S., Marella, L. L., Sangem, A., & Kairam, R. (2019). Where is the evidence? A narrative literature review of the treatment modalities for autism spectrum disorders. Cureus, 11(1), 390\u2013399.","journal-title":"Cureus"},{"issue":"1","key":"4752_CR97","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/aur.1530","volume":"9","author":"H Segal-Gavish","year":"2016","unstructured":"Segal-Gavish, H., Karvat, G., Barak, N., Barzilay, R., Ganz, J., Edry, L., et al. (2016). Mesenchymal stem cell transplantation promotes neurogenesis and ameliorates autism related behaviors in BTBR mice. Autism Research, 9(1), 17\u201332.","journal-title":"Autism Research"},{"key":"4752_CR98","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bbr.2017.03.047","volume":"331","author":"N Perets","year":"2017","unstructured":"Perets, N., Segal-Gavish, H., Gothelf, Y., Barzilay, R., Barhum, Y., Abramov, N., et al. (2017). Long term beneficial effect of neurotrophic factors-secreting mesenchymal stem cells transplantation in the BTBR mouse model of autism. Behavioural Brain Research, 331, 254\u2013260.","journal-title":"Behavioural Brain Research"},{"key":"4752_CR99","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s12035-019-01811-6","volume":"57","author":"C Grasselli","year":"2020","unstructured":"Grasselli, C., Carbone, A., Panelli, P., Giambra, V., Bossi, M., Mazzoccoli, G., et al. (2020). Neural stem cells from Shank3-ko mouse model autism spectrum disorders. Molecular Neurobiology, 57, 1502\u20131515.","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"4752_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13229-020-00366-x","volume":"11","author":"N Perets","year":"2020","unstructured":"Perets, N., Oron, O., Herman, S., Elliott, E., & Offen, D. (2020). Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B. Molecular Autism, 11(1), 1\u201313.","journal-title":"Molecular Autism"},{"issue":"23","key":"4752_CR101","first-page":"4359","volume":"15","author":"M Liu","year":"2011","unstructured":"Liu, M., L\u00fc, Y.-t, Huan, Y., Ge, R.-c, Zhang, J., SGC-Q, J., et al. (2011). Safety and efficacy of cord blood mononuclear cells and umbilical cord mesenchymal stem cells therapy for childhood autism. Chinese Journal of Tissue Engineering. Research, 15(23), 4359\u20134373.","journal-title":"Research"},{"issue":"1","key":"4752_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-196","volume":"11","author":"Y-T Lv","year":"2013","unstructured":"Lv, Y.-T., Zhang, Y., Liu, M., Ashwood, P., Cho, S. C., Huan, Y., et al. (2013). Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. Journal of Translational Medicine, 11(1), 1\u201310.","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"4752_CR103","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/sctm.17-0042","volume":"7","author":"M Chez","year":"2018","unstructured":"Chez, M., Lepage, C., Parise, C., Dang-Chu, A., Hankins, A., & Carroll, M. (2018). Safety and observations from a placebo-controlled, crossover study to assess use of autologous umbilical cord blood stem cells to improve symptoms in children with autism. Stem Cells Translational Medicine, 7(4), 333\u2013341.","journal-title":"Stem Cells Translational Medicine"},{"issue":"2","key":"4752_CR104","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/sctm.18-0251","volume":"8","author":"KL Carpenter","year":"2019","unstructured":"Carpenter, K. L., Major, S., Tallman, C., Chen, L. W., Franz, L., Sun, J., et al. (2019). White matter tract changes associated with clinical improvement in an open-label trial assessing autologous umbilical cord blood for treatment of young children with autism. Stem Cells Translational Medicine, 8(2), 138\u2013147.","journal-title":"Stem Cells Translational Medicine"},{"issue":"164-73","key":"4752_CR105","first-page":"e5","volume":"222","author":"G Dawson","year":"2020","unstructured":"Dawson, G., Sun, J. M., Baker, J., Carpenter, K., Compton, S., Deaver, M., et al. (2020). A phase II randomized clinical trial of the safety and efficacy of intravenous umbilical cord blood infusion for treatment of children with autism spectrum disorder. The Journal of Pediatrics, 222(164-73), e5.","journal-title":"The Journal of Pediatrics"},{"issue":"10","key":"4752_CR106","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/sctm.19-0434","volume":"9","author":"JM Sun","year":"2020","unstructured":"Sun, J. M., Dawson, G., Franz, L., Howard, J., McLaughlin, C., Kistler, B., et al. (2020). Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder. Stem Cells Translational Medicine, 9(10), 1137\u20131146.","journal-title":"Stem Cells Translational Medicine"},{"issue":"2","key":"4752_CR107","doi-asserted-by":"publisher","first-page":"e12445","DOI":"10.1111\/appy.12445","volume":"13","author":"N Sharifzadeh","year":"2021","unstructured":"Sharifzadeh, N., Ghasemi, A., Tavakol Afshari, J., Moharari, F., Soltanifar, A., Talaei, A., et al. (2021). Intrathecal autologous bone marrow stem cell therapy in children with autism: A randomized controlled trial. Asia-Pacific Psychiatry, 13(2), e12445.","journal-title":"Asia-Pacific Psychiatry"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04752-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T10:18:07Z","timestamp":1732789087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04752-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":107,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4752"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04752-y","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,23]]},"assertion":[{"value":"17 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}